Thermoreceptors: How the Body Senses Temperature

Researchers examined how thousands of thermoreceptor nerve cells responded to cool and warm temperatures.
Photo Credit: Dr Phill Bokiniec, The University of Queensland.

Scientific Frontline: Extended "At a Glance" Summary: Thermoreceptor Function in Temperature Detection

The Core Concept: Thermoreceptors are specialized nerve cells that function as the body's primary mechanism for detecting environmental temperatures and relaying this sensory information to the brain. Recent research demonstrates that individual thermoreceptors can signal both warm and cool sensations, rather than being strictly divided into separate, single-function sensors.

Key Distinction/Mechanism: Challenging the previously accepted scientific model that relied on two distinct populations of nerve cells for sensing warmth and cold, new data indicates that a single thermoreceptor can communicate both states. These dual-function receptors operate on a continuum, increasing their neural signaling activity in cooler environments and decreasing their activity as temperatures rise.

Major Frameworks/Components:

• Thermoreceptor Dynamics: The physiological capacity of single neural cells to bidirectionally modulate their activity rates in response to temperature changes, which fundamentally challenges binary sensory models.
• Homeostatic Regulation: The critical role these sensory neural inputs play in the body's ability to maintain a stable internal temperature in response to environmental shifts.
• Thermal Dysfunction Pathology: The impairment of these neural pathways in aging and various disease states, which disrupts proper physiological temperature regulation.

Metabolic Syndrome Accelerates Brain Aging

Abigail Dove.
Photo Credit: Donna Dove

Scientific Frontline: Extended "At a Glance" Summary: Metabolic Syndrome and Brain Aging

The Core Concept: Metabolic syndrome—a cluster of conditions including excess abdominal fat, high blood pressure, high blood sugar, high triglycerides, and low HDL cholesterol—is strongly associated with the accelerated aging of the human brain.

Key Distinction/Mechanism: By applying machine learning to magnetic resonance imaging (MRI) data, scientists can estimate physiological "brain age" and compare it against chronological age. The mechanism connecting metabolic health to this accelerated neurological aging is not entirely direct, but is partially driven by systemic inflammation and altered lipid metabolism.

Major Frameworks/Components:

• Cumulative Neurological Toll: The disparity between estimated brain age and chronological age increases with each additional metabolic syndrome condition, culminating in brains that appear up to 2.3 years older in individuals possessing all five components.
• Biomarker Mediation: Detailed blood analyses indicate that specific apolipoproteins, circulating fatty acids, and inflammatory markers account for 3 to 16 percent of the statistical association between metabolic syndrome and brain aging.
• Independent Component Impact: Even isolated metabolic conditions, such as high blood pressure or high blood sugar alone, demonstrably correlate with an older-looking brain.
• Algorithmic Brain Aging: The utilization of machine learning models to synthesize complex MRI datasets provides a highly precise, quantifiable metric for structural brain deterioration over time.

Feline Models for Human Brain Aging Research

Cats often live long enough to develop age-related brain changes similar to those seen in older humans.
(Shelby)
Photo Credit: Heidi-Ann Fourkiller

Scientific Frontline: Extended "At a Glance" Summary: Feline Models of Human Aging

The Core Concept: Domestic cats naturally develop age-related brain deterioration that closely mirrors human aging, offering a comparative biological model for studying neurodegenerative diseases.

Key Distinction/Mechanism: Unlike laboratory animals with artificially induced diseases and limited lifespans, companion felines share human environments and live long enough to naturally develop comparable brain atrophy, including overall structural shrinkage and ventricular expansion.

Origin/History: Published in Biology Open as part of the Translating Time project, the study represents a collaboration among researchers at the University of Bath, Auburn University College of Veterinary Medicine, and the École Nationale Vétérinaire de Toulouse.

Major Frameworks/Components:

• Synthesis of 3,754 biological data points encompassing brain imaging, blood chemistry, neuropathology, and behavioral milestones across mammalian species.
• Development of a sophisticated, nonlinear biological age-mapping model that replaces simple linear age ratios, demonstrating that biological aging rates fluctuate and that a feline in its mid-teens corresponds to an octogenarian human.
• Utilization of clinical magnetic resonance imaging (MRI) data to observe specific structural neurodegenerative alterations.

Shingles Vaccine Lowers Dementia Risk

Photo Credit: CDC

Scientific Frontline: Extended "At a Glance" Summary: Recombinant Shingles Vaccine (RZV) and Dementia Risk Reduction

The Core Concept: A recent pharmacoepidemiological study indicates that older adults who receive the recombinant shingles vaccine (Shingrix) exhibit a 24% lower risk of being diagnosed with dementia over a four-year period compared to unvaccinated peers.

Key Distinction/Mechanism: Unlike previous observational studies that focused on older live-attenuated vaccines, this research isolates the effects of the newer recombinant zoster vaccine (RZV) on a highly vulnerable demographic entering skilled nursing facilities. While the exact causal mechanism remains unconfirmed, researchers hypothesize the vaccine provides secondary neuroprotective benefits alongside targeted viral suppression.

Major Frameworks/Components:

• Target Trial Emulation: A statistical methodology designed to mimic the conditions and strict parameters of a randomized clinical trial using existing observational health records.
• Pharmacoepidemiology: The application of epidemiological reasoning and methods to study the uses and effects of drugs in well-defined human populations.
• Viral Immunization: The primary function of RZV, preventing the reactivation of the varicella-zoster virus.
• Neuroprotection: The hypothesized secondary outcome of the vaccine, which may help preserve cognitive function and delay the onset of dementia.

Postoperative Delirium & Cognitive Decline

Image Credit: Scientific Frontline / stock image

Scientific Frontline: Extended "At a Glance" Summary: Postoperative Delirium and Cognitive Decline

The Core Concept: Postoperative delirium—a sudden, severe state of confusion and inattentiveness following surgery under anesthesia—is the strongest predictor of long-term cognitive decline in older adults.

Key Distinction/Mechanism: Researchers previously hypothesized that the accelerated cognitive decline following delirium was mediated by subsequent medical complications, frailty, and rehospitalizations. However, this study establishes that delirium directly impacts long-term brain health independent of these secondary medical events, acting as a primary driver rather than a correlated symptom.

Major Frameworks/Components:

• The SAGES Protocol: A longitudinal observational model following 560 adults aged 70 and older.
• Cognitive Assessment Methodology: Utilization of a detailed 11-test cognitive battery administered every six months for 36 months, and annually thereafter for up to six years.
• Variable Isolation: Statistical modeling to separate the cognitive impact of delirium from the impacts of rehospitalizations, intensive care unit (ICU) admissions, and post-acute rehabilitation stays.

Alzheimer's Tau Protein Shapes Memory

Photo Credit: Vitaly Gariev

Scientific Frontline: Extended "At a Glance" Summary: Tau Protein's Role in Long-Term Memory

The Core Concept: The tau protein, heavily associated with cognitive decline in Alzheimer's disease, acts as a fundamental neurological regulator required for organizing, stabilizing, and recalling long-lasting remote memories.

Key Distinction/Mechanism: While tau is not necessary for initial learning or short-term recall, a controlled, low-level chemical modification called phosphorylation allows it to selectively recruit specific brain cells during memory encoding. By minimizing excess brain "noise," tau ensures memory formation is precise; without it, memory traces still form but cannot be naturally accessed through standard sensory cues.

Major Frameworks/Components:

• Engram Cells: Specialized groups of neurons that form the physical, stored trace of a specific memory or experience.
• Remote Memory: Long-term memories that persist and are successfully recalled days or weeks after an initial event.
• Tau Phosphorylation: A subtle chemical modification (specifically tau T205 phosphorylation) that coordinates and regulates the activity of engram cells during the learning process.
• Encoding Window: The critical time frame during learning where tau actively determines which specific neural cells are selected to house the memory.

Neurology: In-Depth Description

Neurology is the branch of medicine and biology concerned with the study, diagnosis, and treatment of disorders of the nervous system. Its primary goal is to understand the structure, function, and pathologies of the central nervous system (the brain and spinal cord), the peripheral nervous system, and the autonomic nervous system, as well as their associated blood vessels and effector tissues, such as muscle.

MouseMapper: AI Analyzes Bodies at the Cell Level

Whole-Body Analysis
MouseMapper automatically segments 31 organs and tissue types in a mouse while simultaneously mapping neural and immune cells throughout the body. This enables comprehensive multi-organ analyses in intact mice.
Image Credit: © Ertürk Lab | Helmholtz Munich

Scientific Frontline: Extended "At a Glance" Summary: MouseMapper AI-Powered Whole-Body Analysis

The Core Concept: MouseMapper is an advanced, AI-powered imaging and analytical system that enables the whole-body analysis of mice down to the single-cell level. It automatically maps neural pathways, immune cells, and organs to visualize pathological changes throughout the entire organism.

Key Distinction/Mechanism: Unlike classical AI systems built for single tasks, MouseMapper utilizes "foundation models"—large AI models trained on vast datasets to recognize general patterns. Combined with tissue clearing and light-sheet microscopy, this deep learning framework flexibly adapts to various datasets to systematically compare changes across 31 different organs and tissues.

Major Frameworks/Components: 

• Tissue Clearing and Light-Sheet Microscopy: Imaging techniques utilized to process and visualize the complex anatomy of the organism at high resolutions.
• Foundation Models: Deep learning AI structures trained to recognize generalized patterns, allowing the flexible mapping of the finest nerve structures and immune cell accumulations.
• Molecular Analysis Integration: The system flags conspicuous regions for further molecular examination to connect cellular damage to specific signaling pathways.

Chemical compound clears cellular waste, protects neurons in model of frontotemporal dementia

Researchers at WashU Medicine have shown that a novel compound they developed can clear a harmful protein from human neurons modeling frontotemporal dementia (shown) and prevent those neurons from dying.
Image Credit: Farzane Mirfakhar

Scientific Frontline: Extended "At a Glance" Summary: Autophagy-Enhancing Compound G2

The Core Concept: A novel chemical compound, an analog of G2, that prevents neuronal death by enhancing autophagy to clear harmful, misfolded tau proteins from brain cells.

Key Distinction/Mechanism: Rather than exclusively targeting the external accumulation of plaques, this compound works intracellularly by restoring the function of lysosomes—the cell's waste-recycling centers—allowing neurons to effectively degrade and eliminate toxic, aggregation-prone proteins.

Major Frameworks/Components:

• Autophagy and Lysosomal Regulation: The cellular waste-clearance systems targeted for therapeutic enhancement to prevent cellular toxicity.
• Pathogenic Tau Protein Aggregation: The disease mechanism where mutated tau proteins misfold, clog lysosomes, and drive neurodegeneration.
• Cellular Reprogramming: The methodology of utilizing neurons derived from patient skin cells to accurately model frontotemporal dementia and test the compound's efficacy.

New AI model can detect multiple cognitive brain diseases from a single blood sample

Two of the researchers behind the AI model, Jacob Vogel and Lijun An, show the results of their study.
 Photo Credit: Emma Nyberg.

Scientific Frontline: Extended "At a Glance" Summary: AI Model for Detecting Multiple Cognitive Brain Diseases

The Core Concept: A novel artificial intelligence model capable of identifying multiple neurodegenerative diseases simultaneously by analyzing complex protein patterns from a single blood sample.

Key Distinction/Mechanism: Unlike traditional diagnostics that test for individual diseases, this model utilizes a process called "joint learning" to identify overarching protein profiles associated with general brain degeneration. It accurately diagnoses and differentiates between five distinct dementia-related conditions—Alzheimer’s disease, Parkinson’s disease, ALS, frontotemporal dementia, and previous stroke—while predicting cognitive decline more effectively than standard clinical diagnoses.

Major Frameworks/Components:

• Joint Learning AI: Advanced statistical machine learning methods that process complex, interconnected data to find general biological patterns across multiple disease presentations.
• Proteomic Profiling: The systematic analysis of protein expression levels in biological samples to map biological functions and disease progression.
• GNPC Database Integration: The model was trained using protein measurements from over 17,000 patients and control participants, drawing from the world’s largest proteomics database for neurodegenerative diseases.

First microlasers capable of detecting individual molecules and ions could one day aid diagnosis

Image Credit: Courtesy of University of Exeter

Scientific Frontline: Extended "At a Glance" Summary: Single-Molecule Microlaser Biosensors

The Core Concept: Researchers have developed microscopic glass bead lasers—measuring between 0.1mm and 0.01mm—capable of acting as highly sensitive optical biosensors. These microlasers can detect materials at an unprecedented scale, identifying individual molecules and single atomic ions.

Key Distinction/Mechanism: The microlasers operate using whispering gallery modes (WGM), where trapped light continuously circles the inner boundary of the glass sphere. When combined with gold nanorods that create nanometer-scale "hot spots," the binding of a single molecule or ion slightly alters the beatnote frequency of the clockwise and counterclockwise laser waves, which researchers measure using self-heterodyne beatnote detection.

Origin/History: The breakthrough was led by Professor Frank Vollmer and Dr. Samir Vartabi Kashanian at the University of Exeter’s Living Systems Institute, funded by the Engineering and Physical Sciences Research Council (EPSRC).

Major Frameworks/Components: 

• Whispering Gallery Modes (WGM): A phenomenon where optical waves travel in a circular path around a concave surface, creating a highly sensitive resonant cavity.
• Plasmonic Enhancement: The use of gold nanorods on the laser's surface to compress and concentrate light into nanometer-scale hot spots, amplifying the signal of single-molecule interactions.
• Self-Heterodyne Beatnote Detection: A technique used to detect minute frequency shifts caused by molecular binding rather than measuring barely perceptible shifts in the light directly.

What Is: Cellular Senescence

In the center, a single senescent "zombie" cell appears aged, enlarged, and distressed. It is actively emitting a glowing, noxious-looking mist or aura (representing the toxic SASP inflammatory factors). Surrounding it are healthy, vibrant, translucent cells
Image Credit: Scientific Frontline

Scientific Frontline: Extended "At a Glance" Summary: Cellular Senescence

The Core Concept: Cellular senescence is a biological paradigm in which a unique subpopulation of cells permanently and irreversibly stops dividing but evades apoptosis (programmed cell death). Instead of dying off, these arrested "zombie cells" remain metabolically hyperactive and linger within mammalian tissues.

Key Distinction/Mechanism: Senescence is distinct from quiescence, which is a temporary, reversible resting state in the G0 phase of the cell cycle. Senescence strictly locks cells in a permanent arrest during the G1 or G2 phases. Rather than clearing out, these cells secrete a complex, toxic cascade of inflammatory factors known as the Senescence-Associated Secretory Phenotype (SASP), which actively drives systemic tissue degradation and remodels the local cellular microenvironment.

Origin/History: The phenomenon was first documented in 1961 by researchers Leonard Hayflick and Paul Moorhead. They discovered that cultured primary human fibroblasts possess a strictly finite replicative lifespan, establishing a biological boundary now universally canonized as the Hayflick limit.

Key Alzheimer’s proteins are competing inside brain cells

Microtubules in blue, tau represented in green, and a-beta in yellow.
Image Credit: Ryan Julian/UCR

Scientific Frontline: Extended "At a Glance" Summary: Intracellular Competition of Alzheimer's Proteins

The Core Concept: Alzheimer's disease pathology may stem from amyloid-beta proteins actively competing with and displacing tau proteins inside neurons, leading to the breakdown of vital cellular transport systems.

Key Distinction/Mechanism: Moving away from the traditional view that extracellular amyloid-beta plaques are the primary cause of Alzheimer's, this model demonstrates that amyloid-beta and tau compete for the exact same binding sites on cellular microtubules. When amyloid-beta accumulates inside the neuron, it displaces tau, causing the microtubule transport system to destabilize and forcing the displaced tau to misbehave, aggregate, and migrate inappropriately.

Major Frameworks/Components:

• Microtubules: Microscopic tubular structures that function as transport "highways" for essential molecules within nerve cells. Without them, neurons cannot move materials required for survival and communication.
• Tau Protein: A protein whose primary healthy function is to bind to and stabilize microtubules.
• Amyloid-beta (a-beta): A protein previously known primarily for forming extracellular plaques, now shown to structurally resemble tau's microtubule-binding region. It binds to microtubules with similar strength to tau.
• Autophagy Decline: The theory integrates the known age-related slowing of the brain's cellular recycling system (autophagy), which normally clears proteins like a-beta before they can accumulate and compete with tau.

Three anesthesia drugs all have the same effect in the brain

Photo Credit: Navy Medicine

Scientific Frontline: Extended "At a Glance" Summary: Universal Mechanism of General Anesthesia

The Core Concept: General anesthesia, regardless of the specific pharmaceutical agent used, induces unconsciousness by fundamentally disrupting the brain's delicate balance between stability and excitability. Although different drugs target varying receptors, they all produce a universal destabilization pattern that ultimately ceases conscious neural activity.

Key Distinction/Mechanism: While the molecular mechanisms differ significantly—propofol inhibits GABA receptors, dexmedetomidine blocks norepinephrine release, and ketamine suppresses NMDA receptors—their macroscopic effect is identical. All three anesthetics push the brain out of "dynamic stability," causing neural networks to take progressively longer to return to their baseline state after processing sensory input (such as auditory tones) until consciousness is entirely lost.

Major Frameworks/Components: 

• Dynamic Stability: The baseline cognitive state where the nervous system maintains a narrow margin of excitability—allowing distinct brain regions to interact without cascading into chaotic neural activity.
• Molecular Target Variance: The diverse biochemical pathways utilized by different anesthetics (GABA modulation, norepinephrine blockade, and NMDA suppression) that converge into a singular destabilizing effect.
• Computational Neural Modeling: The analytical technique used to measure how the brain responds to environmental perturbations and quantify the exact time required to return to a stable baseline.

How Stress Disrupts the Brain’s Navigational System

Which way to go? It is particularly difficult to find your way when you are under stress.
Photo Credit: © RUB, Marquard

Scientific Frontline: "At a Glance" Summary: How Stress Disrupts the Brain's Navigational System

• Main Discovery: The stress hormone cortisol severely disrupts the brain's internal navigational system by impairing the function of grid cells in the entorhinal cortex, causing acute spatial disorientation.
• Methodology: Researchers conducted a functional magnetic resonance imaging study with 40 healthy male participants across two separate sessions. Subjects received either 20 milligrams of cortisol or a placebo before completing a virtual spatial navigation task designed to test their ability to orient and locate direct paths with and without permanent landmarks.
• Key Data: The administration of 20 milligrams of cortisol led to a significantly higher rate of navigational errors among the 40 participants, caused indistinct firing patterns in entorhinal grid cells, and triggered compensatory neural activation in the caudate nucleus.
• Significance: The research identifies a direct neural mechanism by which acute stress hormones destabilize the entorhinal cortex and compromise the brain's internal coordinate maps, verifying the physiological impact of stress on spatial memory.
• Future Application: These findings establish a vital physiological framework for investigating preventative interventions and therapies for dementia and Alzheimer's disease, as the entorhinal cortex is one of the earliest brain regions affected by the condition and chronic stress is a known risk factor.
• Branch of Science: Cognitive Psychology, Neuropsychology, and Neuroscience.
• Additional Detail: Under the influence of cortisol, grid cells lost virtually all function during navigation tasks in environments devoid of permanent landmarks, forcing the brain to attempt to compensate through alternative neural strategies.

Neurobiology: In-Depth Description

Neurobiology is the branch of biology dedicated to the study of the nervous system, focusing on the anatomy, physiology, and pathology of the brain, spinal cord, and peripheral neural networks. Its primary goal is to understand how the cellular and molecular components of the nervous system develop, function, and communicate to drive complex behaviors, cognitive processes, and essential physiological functions.

Scientists discover genetics behind leaky brain blood vessels in Rett syndrome

MIT scientists investigated how genetic mutations that cause the disorder Rett syndrome affect the brain’s blood vessels. The Rett syndrome endothelial cells seen here showed less expression of ZO-1 (green), a key protein for forming a tight seal in blood vessels, than control cells (not pictured). Image Image Credits:Courtesy of the researchers at The Picower Institute for Learning and Memory / MIT

Scientific Frontline: Extended "At a Glance" Summary: Rett Syndrome Vascular Genetics

The Core Concept: Rett syndrome is a severe developmental disorder triggered by mutations in the MECP2 gene, which researchers have recently discovered compromises the structural integrity of developing brain blood vessels. This genetic mutation causes the overexpression of a specific microRNA that breaks down the tight seals of the blood-brain barrier, resulting in vascular leakiness that disrupts neural function.

Key Distinction/Mechanism: While MECP2 is traditionally known to repress the expression of other genes, its mutation in Rett syndrome unexpectedly upregulates miRNA-126-3p. This specific microRNA acts as a mediator that downregulates ZO-1, a crucial protein responsible for sealing the junctions between endothelial cells. Without sufficient ZO-1, the blood vessels become structurally unsound and leak, which subsequently reduces the electrical activity of surrounding neurons.

Major Frameworks/Components: 

• MECP2 Mutations (R306C and R168X): The distinct genetic anomalies that fail to properly regulate gene expression, ultimately initiating the cascade of vascular degradation.
• miRNA-126-3p Upregulation: The specific microRNA pathway identified as the downstream culprit responsible for endothelial cell dysfunction.
• ZO-1 Protein Deficiency: The lack of this critical junction protein, which acts as the "grout" between endothelial cells, leading directly to blood-brain barrier permeability.
• 3D Microvascular Tissue Engineering: The advanced in vitro modeling technique utilizing iPS-derived endothelial cells, fibroblasts, and astrocytes to accurately replicate the human blood-brain barrier.

Gerontology: In-Depth Description

Gerontology is the comprehensive, multidisciplinary study of aging and older adults. Its primary goals are to understand the complex biological, psychological, and social processes that occur as organisms age, and to apply this knowledge to maximize the health, independence, and overall quality of life for aging populations. Unlike geriatrics—which is the specific medical specialty focused on diagnosing and treating diseases in the elderly—gerontology examines the aging process itself across the entire lifespan.

Tracking single red blood cells as they move through the brain

Song Hu and his collaborators have developed super-resolution functional photoacoustic microscopy (SR-fPAM), which allows researchers to image blood flow and oxygenation at single-cell resolution in the mouse brain. It bridges a critical gap in functional microvascular imaging and could provide new insight into microvascular health and disease, such as stroke, vascular dementia and Alzheimer’s disease.
Image Credit: Song Hu, created with Manus

Scientific Frontline: "At a Glance" Summary: Single-Cell Red Blood Cell Tracking in the Brain

• Main Discovery: Super-resolution functional photoacoustic microscopy enables the imaging of blood flow and oxygenation at single-cell resolution within the mouse brain without requiring cellular contrast labels.
• Methodology: A high-speed photoacoustic microscope illuminates brain tissue with short laser pulses to generate ultrasound waves from hemoglobin. Images of the same brain region are acquired at millisecond intervals, allowing the computational accumulation of red blood cell trajectories across sequential frames to reconstruct three-dimensional microvascular structures.
• Key Data: The imaging system operates at millisecond intervals and successfully documented the instant redirection of red blood cell flow and oxygen delivery across three-dimensional microvascular networks following an induced stroke and the subsequent occlusion of a single microvessel.
• Significance: Bridging a critical spatial resolution gap in functional microvascular imaging allows for the direct observation of hemodynamic changes and vascular adaptations associated with cerebral small vessel disease, stroke, vascular dementia, and Alzheimer's disease.
• Future Application: Planned integration with two-photon microscopy will enable simultaneous tracking of individual red blood cells and neurons to study their spatiotemporal coordination, potentially improving clinical neuroimaging interpretation and guiding early detection strategies for cognitive impairment.
• Branch of Science: Biomedical Engineering and Neuroscience.

Early Alzheimer's increased connectivity lowered by cancer drug in the lab

Neurons exposed to amyloid-beta formed more connections (SSBs = single synaptic boutons), which could be lessened with cancer drug eFT508.
Image Credit: Figure reproduced from Wu et al. 2026

Scientific Frontline: Extended "At a Glance" Summary: Early Alzheimer's Hyperconnectivity and eFT508

The Core Concept: In the earliest stages of Alzheimer's disease, typically correlating with Mild Cognitive Impairment (MCI), low levels of the amyloid-beta protein induce an abnormal increase in neural connections (hyperconnectivity) prior to widespread cell death and memory loss.

Key Distinction/Mechanism: Challenging the traditional model that Alzheimer's begins primarily with synapse loss, this research demonstrates that the disease may actually initiate with too many poorly organized connections. Amyloid-beta rewires, rather than simply increases or decreases, cellular protein production, pushing neurons into an unstable state. The experimental cancer drug eFT508, which targets MAP kinase interacting kinase (MNK), successfully prevented this hyperconnectivity and restored normalized protein production in laboratory models.

Major Frameworks/Components:

• Amyloid-Beta Induced Synaptogenesis: Exposure to low doses of amyloid-beta over a short five-day period triggers hyperconnectivity and creates a self-reinforcing loop by upregulating the amyloid precursor protein.
• Expansion Microscopy: A state-of-the-art imaging technique that expands biological samples 5 to 6 times, enabling researchers to visualize and quantify individual synapses as small as 30 nanometers.
• Liquid-Chromatography Mass-Spectrometry: An analytical method used to profile internal neuronal changes, identifying 49 specific proteins whose production was altered by amyloid-beta exposure.
• MNK Inhibition (eFT508): The pharmacological mechanism utilized by the repurposed cancer drug to decrease neuroinflammation, inhibit abnormal protein synthesis, and restore approximately 70% of altered protein production.